ARCHIVES

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

This article is from The Cancer Letter archive.

Vol. 03 No. 21 | May 27, 1977

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Feinstein Introduces New Cancer Act; Groups Say Bill Flawed

March 15, 2002

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

In Brief: Community ASSN. Developing Clinical Standards Catalogue; Perry Leaves NCI For NIH Position

November 15, 1974

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001